A carregar...

Costs to Health Services and the Patient of Treating Tuberculosis: A Systematic Literature Review

BACKGROUND: Novel tuberculosis (TB) drugs and the need to treat drug-resistant tuberculosis (DR-TB) are likely to bring about substantial transformations in TB treatment in coming years. An evidence base for cost and cost-effectiveness analyses of these developments is needed. OBJECTIVE: Our objecti...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Pharmacoeconomics
Main Authors: Laurence, Yoko V., Griffiths, Ulla K., Vassall, Anna
Formato: Artigo
Idioma:Inglês
Publicado em: Springer International Publishing 2015
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4559093/
https://ncbi.nlm.nih.gov/pubmed/25939501
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40273-015-0279-6
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!